Pulmonary embolism in COVID-19, risk factors and association with inflammatory biomarkers

Pulmonary embolism in COVID-19, risk factors and association with inflammatory biomarkers

<div><p>The coronavirus disease 2019 (COVID-19) pandemic affected millions of people worldwide resulting in a substantial number of hospitalizations. Venous thromboembolism including pulmonary embolism is a known complication of COVID-19 pneumonia although its incidence in such patients...

Full description

Saved in:
Bibliographic Details
Main Author: Muhammad Yousaf (754345) (author)
Other Authors: Merlin Marry Thomas (17844200) (author), Salah Almughalles (17945636) (author), Mansoor Ali Hameed (17945639) (author), Ahmad Alharafsheh (17945642) (author), Irfan Varikkodan (17945645) (author), Ali Waseem (17945648) (author), Mona Babikir (17945651) (author), Dinesh Chengamaraju (14777146) (author), Mohamad Yahya Khatib (14152437) (author)
Published: 2023
Subjects:
Biomedical and clinical sciences
Clinical sciences
COVID-19
critical illness
CTPA
D-Dimer
pulmonary embolism
venous thromboembolism
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items